The TP53 gene, frequently altered in NSCLC patients,49 enhances tumour cell proliferation and invasiveness when activated; its inhibition markedly induces apoptosis in NSCLC cells.50 This evidence concerns the gene TP53 and non-small cell lung carcinoma.